<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> caused by atherosclerotic carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (ACAO) should receive intravenous tissue plasminogen activator if they meet eligibility criteria </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> caused by ACAO who are not eligible for intravenous tissue plasminogen activator should receive aspirin </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> or <z:chebi fb="5" ids="28304">heparin</z:chebi>-like drugs do not improve outcome and should not be used </plain></SENT>
<SENT sid="3" pm="."><plain>Therapy for prevention of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> in patients with ACAO should consist of lifestyle modifications, risk factor intervention, and aspirin </plain></SENT>
<SENT sid="4" pm="."><plain>Other antiplatelet drugs should be considered in patients with contraindication to aspirin </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi> is not indicated </plain></SENT>
<SENT sid="6" pm="."><plain>Extracranial-intracranial bypass surgery provides no benefit over medical therapy in preventing recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> in a general population of patients with ACAO or in any subgroups selected by clinical or arteriographic criteria </plain></SENT>
<SENT sid="7" pm="."><plain>Extracranial-intracranial bypass surgery in patients selected by hemodynamic criteria should only be performed as part of a randomized controlled clinical trial </plain></SENT>
<SENT sid="8" pm="."><plain>Other surgical or endovascular procedures have no proven value in treating or preventing <z:hpo ids='HP_0001297'>stroke</z:hpo> caused by ACAO </plain></SENT>
<SENT sid="9" pm="."><plain>Asymptomatic carotid occlusion has a benign prognosis, and requires no specific treatment other than lifestyle modification and risk factor intervention </plain></SENT>
</text></document>